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http://dx.doi.org/10.1016/j.stemcr.2016.06.005SUMMARYThe molecular mechanisms regulating neural progenitor (NP) proliferation are fundamental in establishing the cytoarchitecture of the
mammalian neocortex. The rate of cell-cycle progression and a fine-tuned balance between cell-cycle re-entry and exit determine the
numbers of both NPs and neurons as well as postmitotic neuronal laminar distribution in the cortical wall. Here, we demonstrate that
themicroRNA (miRNA)miR-210 is required for normalmouseNP cell-cycle progression.Overexpression ofmiR-210 promotes premature
cell-cycle exit and terminal differentiation inNPs, resulting in an increase in early-bornpostmitotic neurons. Conversely,miR-210 knock-
downpromotes an increase in the radial glial cell population and delayed differentiation, resulting in an increase in late-born postmitotic
neurons.Moreover, the cyclin-dependent kinaseCDK7 is regulated bymiR-210 and is necessary for normalNP cell-cycle progression.Our
findings demonstrate that miRNAs are essential for normal NP proliferation and cell-cycle progress during neocortical development.INTRODUCTION
The neocortex, also called the dorsal cortex, is an
immensely complex mammalian brain structure that con-
trols higher cognitive functions, such as problem solving
and reasoning, sensory perception, emotional processing,
and attention. The developing neocortex is populated by
several major types of neural progenitors (NPs) that pri-
marily give rise to the excitatory neurons that populate
the cortical wall (Florio and Huttner, 2014; Gertz et al.,
2014). The mouse neocortex consists of self-renewing
radial glial cells (RGCs) that reside in the ventricular
zone (VZ) and give rise to postmitotic neurons as well as
intermediate progenitors (IPs), which populate the sub-
ventricular zone (SVZ). These NP populations generate
most of the neurons in the cortical plate (CP) (Englund
et al., 2005; Franco and Muller, 2013; Sessa et al., 2008).
As progenitors exit the cell cycle and terminally differen-
tiate, early-born neurons migrate away from the VZ/SVZ
to form the deeper layers of the cortex, and late-born neu-
rons migrate past these cells to populate the outer layers,
thereby forming an inside-out six-layer structure charac-
teristic of the mammalian cortex (Kowalczyk et al., 2009;
Toma et al., 2014).
Regulation of proliferation in NPs must be tightly
controlled, as the length of the cell cycle and the timing
of cell-cycle exit determine the size of the NP and postmi-
totic neuron population, and the laminar positioning
of mature neurons within the six layers of the cortical
wall (Taverna et al., 2014). Regulators of cell-cycle progres-
sion play crucial roles in neocortical development andSte
This is an open access article under the Cexpansion (Chenn and Walsh, 2002, 2003; Pilaz et al.,
2009). Consequently, investigating the genes and pro-
cesses involved in neocortical development should provide
insight into the development and remarkable evolutionary
expansion of the cortex observed in higher mammals,
as well as neurodevelopmental disorders that arise from
abnormal NP proliferation and differentiation (Kriegstein
et al., 2006; Rakic, 2009; Sun and Hevner, 2014).
MicroRNAs (miRNAs) are a class of small, noncoding
RNAs that have recently emerged as important regulators
of neural development (Fineberg et al., 2009; Shibata
et al., 2011). Previous work has demonstrated that miRNAs
are essential for normal neocortical development (Bian
et al., 2013; Kawase-Koga et al., 2010; Nowakowski et al.,
2013; Pollock et al., 2014). Mice lacking dorsal cortical
expression of the miRNA-processing molecule Dicer, and
thus, expression of most miRNAs, develop abnormally
small cortices (Davis et al., 2008; Kawase-Koga et al.,
2009). This evidence suggests that miRNAs are required
for cortical development; however, the specific miRNAs
that regulate neurogenesis in the neocortex are still being
uncovered.
miRNA-210 (miR-210) has previously been described
to regulate tissue development, tumorigenesis, and post-
ischemia (Biswas et al., 2010; Huang et al., 2009). Overex-
pression of miR-210 in non-neural tissues impairs prolifer-
ation (He et al., 2013; Tsuchiya et al., 2011; Zhang et al.,
2009). Further, gene ontology analysis of predicted and
verified mRNA targets of miR-210 reveal that many are
involved in regulating the cell cycle and, possibly, in neural
development (Fasanaro et al., 2009). Taken together, thesem Cell Reports j Vol. 7 j 69–79 j July 12, 2016 j ª 2016 The Author(s). 69
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. miR-210 Is Expressed in the
Developing Mouse Neocortex
(A) The mature miR-210 sequence is highly
conserved across species. The conserved
seed sequence of miR-210 is shown in blue
and the variation in sequences among spe-
cies is shown in red.
(B and C) Expression pattern of miR-210 in
embryonic day 13.5 (E13.5) (B) and E15.5
(C) mouse cortices, as detected by in situ
hybridization. miR-210 was expressed in
neural progenitors in the ventricular zone
(VZ, arrowheads) of the E13.5 cortex (B),
and the VZ and subventricular zone (SVZ,
arrows) at E15.5 (C). miR-210 was also ex-
pressed in the cortical plate (CP) of E15.5
neocortex (C).
(D) Expression of miR-210 in mouse dorsal
cortices at different developmental stages,
as detected by qRT-PCR. Expression was
normalized to P0. The ubiquitously ex-
pressed Gapdh was used as an internal
control.
(E) Expression of miR-210 in mouse dorsal
cortices at different developmental stages,
as detected by the northern blotting assay.
The ubiquitously expressed small non-
coding RNA U6 was used as a loading
control.
(F) Expression of miR-210 in mouse neurospheres, cultured from E12.5 cortical neural stem cells, and in P14 cortex, detected by qRT-PCR.
U6 was used as an internal control.
Scale bar, 20 mm. Data are presented as means ± SEM; n = 3 individual brain samples at each time point; p values in relation to control
(*p < 0.05). N.S., not significant.data suggests that miR-210 is a promising potential regu-
lator of NP proliferation and differentiation.
Here, we demonstrate that miR-210 is expressed in NPs
throughout neocortical development and is an important
regulator of NP proliferation. We show that altering miR-
210 expression levels disrupts cell-cycle progression, ulti-
mately altering the number and final laminar position of
NP-derived postmitotic neurons. We also verify cyclin-
dependent kinase 7 (Cdk7) as a target of miR-210 and an
important regulating factor in the NP cell cycle. Our results
suggest that proper expression levels of CDK7 andmiR-210
are required for normal neocortical development.RESULTS
miR-210 Regulates Proliferation in Radial Glial Cells
and Intermediate Progenitors
In our preliminary screen, we comparedmiRNA expression
levels in the mouse neocortex at embryonic day 12.5
(E12.5) and postnatal day 0 (P0). We identified an miRNA,
miR-210, which shows high expression at E12.5 and P0.We70 Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016speculated that miR-210 plays a role in regulating NP pro-
liferation. Based on analysis of its seed sequence and
genomic context, miR-210 does not belong to a large fam-
ily or cluster of miRNAs, and its seed sequence is conserved
in invertebrates and vertebrates (Figure 1A). Consequently,
we analyzed only the predominant mouse miR-210-3p
strand, termed miR-210 for this study.
We first examined miR-210 expression in the mouse
neocortex during development using in situ hybridization.
miR-210was expressed in NPs in the VZ at E13.5, and in the
VZ, SVZ, and early-born neurons in the CP at E15.5 (Figures
1B and 1C). Northern blotting assay and real-time quan-
titative RT-PCR (qRT-PCR) confirmed that miR-210 is
expressed in the neocortex during early neurogenesis
(E13.5). Its expression increased at the peak of neurogene-
sis (E15.5–E17.5) and slightly decreased at the postnatal
stage (Figures 1D and 1E). Moreover, we cultured neural
stem cells, collected from E12.5 neocortex, to form neu-
rospheres and compared miR-210 expression in neuro-
spheres and cortical tissues at P14. miR-210 expression
was detected in neurospheres and its expression increased
at P14 (Figure 1F).
Figure 2. miR-210 Regulates Neural Progenitor Proliferation
(A) Illustration of in utero electroporation tissue collection. Electroporation was performed at E13.5, followed by BrdU incorporation at
23 hr, and tissue analyzed at E14.5.
(B–E) Overexpression (miR-210) and sponge-mediated knockdown (sp-210) of miR-210 decreased expression of proliferative markers
BRDU (B and C) and KI67 (D and E) in GFP-positive cells.
(F–I) Overexpression of miR-210 decreased RGC marker PAX6 expression in GFP-positive cells, while sp-210 expression increased it
(F and G). Both miR-210 and sp-210 expression decreased expression of the IP marker TBR2 (H and I).
Scale bar, 20 mm. Data are presented as means ± SEM; n = 6 individual brains for all constructs; p values in relation to control (*p < 0.05,
***p < 0.001). N.S., not significant.To determine the function of miR-210 in the regulation
of the NP pool in the developing neocortex, we manipu-
lated miR-210 expression in the ventricular NPs using inutero electroporation at E13.5 and collected the tissue on
E14.5, 24 hr post-electroporation (Figure 2A). To overex-
press miR-210, we designed a construct that contains theStem Cell Reports j Vol. 7 j 69–79 j July 12, 2016 71
mouse miR-210 precursor sequence. Moreover, miR-
210 knockdown was achieved through application of an
miRNA sponge, specific to miR-210, here called miR-210
sponge (sp-210) (Otaegi et al., 2011). Overexpression of
miR-210 resulted in a pronounced reduction in prolif-
eration compared with vector controls, as measured by
incorporation of the cell-cycle S-phase marker bromodeox-
yuridine (BRDU) (Figures 2B and 2C). Interestingly, miR-
210 did not appear to impair other mitotic phases, as
KI67 labeling was unchanged in miR-210 overexpression
cells (Figures 2D and 2E). However, sp-210 impaired
S-phase entry compared with the control and resulted in
a more pronounced cell-cycle impairment, and induced a
reduction in KI67 expression, suggesting that inhibition
of miR-210 function affects more than one mitotic phase
(Figures 2B–2E).
Furthermore, because PAX6 and TBR2 have been shown
to label RGCs and IPs, respectively, we examined whether
the number of RGCs and IPs is affected by miR-210 (En-
glund et al., 2005). miR-210 overexpression resulted in a
reduction in the size of both of the RGC (PAX6+ cells)
and IP (TBR2+ cells) populations, which indicates that the
miR-210-induced cell-cycle defect impairs proliferation in
the entire NP pool (Figures 2F–2I). Noticeably, sp-210 over-
expression induced a similar reduction in the size of the IP
population compared with control. However, sp-210 pro-
moted a striking increase in the size of the RGC pool (Fig-
ures 2F–2I). These results indicate that sp-210 negatively
regulates cell-cycle progression in RGCs and reduces their
transition to IPs, thereby decreasing the size of the IP pool.
To verify the specificity of sp-210, we generated an miR-
210 sponge mutation (mut-sp-210), which is identical to
sp-210 except for three mismatches in the target-binding
site. Mut-sp-210 had no effect on proliferation in NP pop-
ulations and RGCs and IPs, indicating that sp-210, not its
mutation, can specifically knock down miR-210 in vivo
(Figure S1). Our results suggest that precise levels of miR-
210 expression are crucial for regulating proliferation in
NPs and maintaining the size of distinct NP populations
in the embryonic neocortex.
miR-210 Regulates Neural Progenitor Cell-Cycle Exit
Wenext investigated the function ofmiR-210 in regulating
cell-cycle parameters, specifically, the labeling index and
the cell-cycle-exit index. The labeling index, the propor-
tion of cells entering the cell cycle, is measured by quanti-
fying BrdU incorporation in all cycling cells (GFP+KI67+).
Cell-cycle exit is measured by the number of cells that
exit the cell cycle within 24 hr of BRDU incorporation
(GFP+BRDU+KI67) versus the total number of cycling cells
(GFP+KI67+).
In brain tissue collected 24 hr post-electroporation, cells
overexpressing miR-210, but not sp-210, displayed a72 Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016decreased labeling index compared with controls, suggest-
ing that miR-210 overexpression but not its knockdown re-
duces the fraction of cycling NPs reentering the cell cycle
(Figures 3A and 3B). For cell-cycle exit analysis, brain tissue
was collected 48 hr post-electroporation and 24 hr post-
BrdU incorporation (Figure 3C). miR-210 overexpression
resulted in an increased rate of NP exit from the cell cycle.
Similarly, sp-210 expressing cells also exit the cell cycle at
an elevated rate (Figures 3D and 3E). These results indicate
that miR-210 regulates the S-G1 cell-cycle transition in
NPs, where cells decide either to reenter or exit the cell cy-
cle (Figure 3F). Elevated miR-210 levels cause decreased NP
cell-cycle entry, increased cell-cycle exit, and a reduction in
the entire progenitor pool (Figure 3G). miR-210 knock-
down results in increased RGCs, decreased IP proliferation,
and decreased population size, likely because the RGCs
remain arrested in the cell cycle and fail to give rise to IPs
(Figure 3H).
miR-210 Targets Cdk7, a Cell-Cycle Regulator and
Cyclin Activating Kinase
miRNAs function through silencing target genes, as a few
studies have shown a targeting effect ofmiR-210 (Friedman
et al., 2009). Because we found that miR-210 regulates cell-
cycle progression in the developing neocortex, we sought
to identify miR-210 target genes that might play a role in
controlling the cell cycle in NPs. Among predicted miR-
210 targets, we found that the 30UTR of Cdk7 contains a
binding site formiR-210 (Figure 4A). CDK7, a cyclin-depen-
dent kinase (CDK) activating kinase (CAK) that targets and
activates numerous other CDKs, regulates several cell-cycle
checkpoints and is required for S-phase entry (Ganuza
et al., 2012; Ganuza and Santamaria, 2012; Rossi et al.,
2001; Schachter et al., 2013).
To verify Cdk7 as a target of miR-210, we used a luciferase
assay by cloning the 30UTR of Cdk7 into a luciferase vector,
which was then co-transfected with miR-210. Luciferase
activity in constructs containing the Cdk7 30UTR was
significantly reduced bymiR-210, while the controlmiRNA
miR-9 did not affect luciferase activity, suggesting thatmiR-
210 specifically binds the 30UTR of Cdk7 (Figure 4B). More-
over, co-transfection of sp-210 with miR-210 partially
rescued the reduction in luciferase activity, while mut-
sp-210 had no rescuing effect, demonstrating the effec-
tiveness and specificity of sp-210 at reducing miR-210
target-binding activity (Figure 4B). These results indicate
that Cdk7 is a putative target for miR-210.
Reducing Expression of themiR-210 Target Gene Cdk7
Impairs Neural Progenitor Proliferation
We next determined if CDK7 is expressed in NPs by co-
staining the embryonic neocortex with CDK7 and the NP
marker NESTIN. CDK7 was expressed in NPs in the VZ at
Figure 3. miR-210 Regulates S-Phase Entry and Cell-Cycle Exit in Neural Progenitors
(A and B) miR-210 but not sp-210 overexpression in the E13.5 mouse brain, analyzed at E14.5, decreased the proportion of cells entering
the S phase or the BrdU labeling index.
(C) Illustration of in utero electroporation timeline for tissue collection. Electroporation was performed at E13.5, followed by BrdU
incorporation at E14.5, and tissue analyzed at E15.5.
(D and E) miR-210 and sp-210 increased the proportion of cells exiting the cell cycle.
(F) Model of miR-210 regulation of NP proliferation. Endogenous expression of miR-210 promotes normal proliferation in RGCs and IPs.
(G) Elevated miR-210 expression induces a decrease in proliferation and an increase in cell-cycle exit in both RGCs and IPs, thus reducing
the NP pool.
(H) Attenuated miR-210 expression using miR-210 sponge increases the population size of the RGCs, which fail to transition to IPs,
resulting in an increased RGC pool and decreased IP pool.
Scale bar, 20 mm. Data are presented as means ± SEM; n = 5 individual brains for all constructs; p values in relation to control (*p < 0.05,
**p < 0.01). N.S., not significant.
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Figure 4. Cdk7 Is a Putative Target of miR-210 in the Regulation of Proliferation in Neural Progenitors
(A) The Cdk7 30UTR contains a target-binding site for miR-210.
(B) Luciferase activity in a luciferase vector containing the Cdk7 30UTR was reduced by miR-210 expression. Co-expression of sp-210, but
not mutated sp-210 (mut-sp-210), partially rescued the luciferase activity. n = 3 biological replicates.
(C) Expression pattern of CDK7 in E13.5 and E15.5 mouse cortices, as detected by immunohistochemistry. CDK7 was co-expressed with the
NP marker NESTIN in the ventricular zone (VZ) and subventricular zone (SVZ) (arrowheads).
(D and E) shRNA-mediated knockdown of Cdk7 (shCdk7) decreased BRDU and KI67 expression in GFP-positive cells.
(F and G) shCdk7 decreased PAX6 and TBR2 expression in GFP-positive cells.
Scale bar, 20 mm. Data are presented as means ± SEM; n = 5 individual brains for all constructs; p values in relation to control (*p < 0.05,
**p < 0.01, ***p < 0.001). N.S., not significant.E13.5 and E15.5, as well as in the CP, similar to the expres-
sion pattern of miR-210, suggesting an overlapping expres-
sion of miR-210 and its target CDK7 in the developing
neocortex (Figure 4C).
We next investigated the role of Cdk7 in NP proliferation
by manipulating expression levels of Cdk7 using in utero
electroporation at E13.5. To thoroughly examine Cdk7
function, four shRNA constructs were designed and exam-74 Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016ined to knock down expression of Cdk7. Among them,
shCdk7-1 and shCdk7-4 showed a stronger knockdown ef-
fect, with the former inducing a more pronounced reduc-
tion in Cdk7 expression, as detected by both qRT-PCR
and western blotting assay (Figures S2A and S2B). More-
over, shCdk7-1 also reduced endogenous Cdk7 expression
in the E17.5 cortex, electroporated at E13.5 (Figures S2C
and S2D). Moreover, overexpression of Cdk7 resulted in a
Figure 5. Knockdown of Cdk7 Impairs
Cell-Cycle Entry but Has No Effect on
Cell-Cycle Exit
(A and B) shCdk7 expression in the E13.5
mouse brain, analyzed at E14.5, decreased
the proportion of cells entering the S phase
or the BrdU labeling index. To compare the
effect of shCdk7, miR-210, and sp-210 on the
BrdU labeling index, the same control shown
in Figure 3A is displayed here.
(C and D) shCdk7 expression in the E13.5
mouse brain, analyzed at E15.5, had no ef-
fect on the proportion of cells exiting the
cell cycle compared with the control.
Scale bar, 20 mm. Data are presented as
means ± SEM; n = 5 individual brains for all
constructs; p values in relation to control
(*p < 0.05). N.S., not significant.dramatic increase in cell death, such that electroporated
cells did not survive longer than 24 hr for analysis (Figures
S2E and S2F).
Furthermore, shCdk7-1 resulted in a reduction in the
number of NPs and the RGC and IP populations (Figures
4D–4G). These results are similar to that observed in
miR-210 overexpression (Figure 2). shCdk7-4 induced a
similar but less pronounced reduction in NP proliferation
compared with shCdk7-1, which further confirms the
effect of Cdk7 knockdown (Figure S3). Moreover, while
shCdk7-1 did not promote cell-cycle exit in NPs, it
induced a decrease in the NP labeling index (Figure 5).
These results suggest that miR-210 and CDK7 are both
important regulators of the cell cycle in NPs, and
their balanced expression maintains normal mitotic
progression.
miR-210 Promotes Premature Differentiation of
Neural Progenitors
Because altered cell-cycle regulation of NPs affects neuro-
genesis, we next investigated the function of miR-210 in
NP terminal differentiation, using markers for early-born
deep-layer neurons and late-born superficial-layer neurons,
TBR1 and SATB2, respectively. To analyze NP differentia-
tion, tissue was collected 4 days post-electroporation (Fig-
ure 6A). At E17.5, a higher proportion of miR-210 overex-
pressing postmitotic neurons co-expressed the deep-layer
marker TBR1, while a lower proportion co-expressed the
superficial-layer marker SATB2 compared with controls
(Figures 6B–6E). Furthermore, cells overexpressing miR-
210 populated deeper layers in the cortical wall compared
with controls, suggesting that they were born earlier (Fig-
ure 7). Conversely, a decreased proportion of sp-210-ex-
pressing neurons co-expressed TBR1, with no significantchange in SATB2-expressing cells (Figures 6B–6E), and an
increased proportion populated the outermost layers of
the cortex compared with controls, suggesting that they
were born later (Figure 7).
Furthermore, because migration of postmitotic neu-
rons continues into the first postnatal week after the
neurogenesis peak by E17.5 (Marin and Rubenstein,
2003), we then analyzed postmitotic cells on P5,
10 days post-electroporation (Figure S4A). We found
that miR-210- and sp-210-expressing cells populate the
deeper and more superficial layers of the cortex, respec-
tively (Figures S4B–S4E). Moreover, sp-210-expressing
cells were more likely to express the late-born neuronal
marker SATB2 (Figures S4F and S4G), suggesting that
the altered position of postmitotic neurons in the
cortical wall is indicative of their birth date and is not
transient, and that miR-210 is promoting deep lamina-
tion (Figure S5).DISCUSSION
Expansion of theNPpopulation is thought to have contrib-
uted to the dramatic increase in the surface area of the
neocortex (or neocorticalization) observed in higher mam-
mals (Kriegstein et al., 2006; Rakic, 2009; Sun and Hevner,
2014). Thus, maintenance of the NP pool size and the rate
of proliferation are crucial for normal cortical development
and expansion. Here, we demonstrate that CDK7 and
miR-210 play an important role in regulating cell-cycle pro-
gression as well as terminal differentiation in mouse NP
populations, thereby helping to determine the birth date
and laminar positioning of postmitotic neurons in the
cortex.Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016 75
Figure 6. miR-210 Promotes Premature Differentiation in Neural Progenitors
(A) Illustration of in utero electroporation timeline for tissue collection. Electroporation was performed at E13.5 and tissue analyzed at
E17.5.
(B–E) Overexpression of miR-210 increased the early-born neuronal marker TBR1 (B and C) and decreased the late-born neuronal marker
SATB2 (D and E) in GFP-positive cells. Sp-210 decreased TBR1 expression in GFP-positive cells (C).
VZ, ventricular zone; SVZ, subventricular zone; IZ, intermediate zone; CP, cortical plate.
Scale bar, 20 mm. Data are presented as means ± SEM; n = 5 individual brains for all constructs; p values in relation to control (*p < 0.05,
**p < 0.01). N.S., not significant.In the mouse neocortex, generation of neurons peaks at
approximately E15.5, at which time NP divisions have
switched from asymmetric proliferative divisions to pri-
marily symmetric neurogenic divisions (Miyata et al.,
2004; Noctor et al., 2004). Lengthening of the NP cell cy-
cle is thought to be one of the major factors regulating
this switch (Dehay and Kennedy, 2007). Many cell-cycle
regulators, both coding genes and miRNAs, are involved
in regulating cell-cycle parameters in NPs (Buttitta and
Edgar, 2007; Quinn et al., 2007). In this study, we show
that overexpression and knockdown of miR-210 in NPs
is sufficient to hinder the cell cycle, suggesting that
optimal levels of miR-210 maintain proper cell-cycle
progression. Overexpression of miR-210 consistently at-
tenuates cell-cycle progression, across tissue types and
environmental contexts, evincing that miR-210 plays a
conserved role and directly or indirectly inhibits mito-
genic function (He et al., 2013; Tsuchiya et al., 2011;
Zhang et al., 2009).
Like most miRNAs, miR-210 functions by binding to
and inhibiting its mRNA targets and modulates their
expression levels (Bartel, 2004; Schratt, 2009). Here, we
have found that miR-210 regulates the expression of the76 Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016cell-cycle regulating molecule Cdk7, a kinase that is essen-
tial for all eukaryotic cell cycles. In non-neural cell types,
ablation of Cdk7 expression induces cell-cycle arrest. We
found that reduction of Cdk7 expression in NPs, much
like overexertion of miR-210, yields a pronounced reduc-
tion in proliferation in both RGCs and IPs. This evidence
indicates that Cdk7 and miR-210 may coordinate to
promote NP cell-cycle progression. miR-210 may modu-
late Cdk7 expression levels to ensure that NPs enter and
exit the cell cycle at an appropriate rate during cortical
development.
ElevatedmiR-210 expression promotes cell-cycle exit, de-
creases the RGC and IP populations, and results in a reduc-
tion of the entire NP pool. miR-210 overexpression appears
to force NPs out of the cell cycle prematurely, likely by in-
hibiting transition from G1 to S phase. As a consequence,
later in development, at E17.5 and P5, cells overexpressing
miR-210 populate the deeper layers of the cortex and
become early-born neurons at higher proportions than
controls. miR-210 knockdown also induces a proliferation
impairment, selectively reducing the IP population and
increasing the RGC population. This suggests that sp-
210-expressing RGCs remain in the cell cycle and do not
Figure 7. miR-210 Promotes a Deep-Layer Location of Neurons in the Cortex
(A and B) Electroporation was performed at E13.5 and tissue analyzed at E17.5. Overexpression of miR-210 promoted a deep location of
neurons in the cortical wall, while sp-210 induced a superficial location compared with empty vector controls (A). Relative numbers of GFP+
cells in each bin in the cortical wall are plotted in (B).
(C–F) Electroporation was performed at E13.5 and tissue analyzed at E17.5. Overexpression of miR-210 promoted deep localization within
the TBR1 and SATB2 zones of expression. Sp-210 induced outer localization within the TBR1 and SATB2 zones of expression. Relative
numbers of GFP+ cells in each bin in the cortical wall are plotted in (D and F). Control brains for GFP/TBR1 and GFP/SATB2 labeling, shown
in Figures 6B and 6D, are displayed here for quantification of neuronal migration.
Scale bar, 20 mm. n = 5 individual brains for all constructs.transition to IPs at the same rate as controls, possibly due to
RGC cell-cycle arrest at G0 resulting fromdisrupted S-phase
entry (Figure S5). At P5, sp-210-expressing cells are more
likely to be late-born superficial neurons than controls (Fig-
ure S5). Our finding indicates that overexpression and
knockdown of miR-210 have similar but distinct effects
on cell-cycle progression in NPs. Together with CDK7,
miR-210 fine-tunes proliferation and differentiation of
cortical NPs and ensures establishment of proper lamina-
tion in the neocortex.
Because miR-210 is a conserved miRNA expressed in NPs
at crucial points during neocortical development, it is likely
that there are targets of miR-210 other than Cdk7, which
also function in the regulation of cell-cycle progression in
the cortex. Identifying targets and regulators of miR-210
that may contribute to its function of cell-cycle regulation
inNPs will help provide amore complete picture of the role
of miR-210 in the developing neocortex. In this study, our
results suggest that miR-210 is an important regulator of
cell-cycle progression, exit, and terminal differentiation
in NPs of the developing neocortex, acting at least
partially through regulation of Cdk7. Our work providesfurther insight into the vital role of miRNAs in cortical
development.EXPERIMENTAL PROCEDURES
Tissue Preparation and Immunohistochemistry
Wholemouse brains were fixed overnight in 4% paraformaldehyde
(PFA) in PBS, incubated in 30% sucrose in PBS overnight, embedded
inoptimal cutting temperature compound, and stored at80Cun-
til use. Brains were sectioned (12–16 mm) using a cryostat. For anti-
gen retrieval, sectionswere immersed in heated (95–100C) antigen
recovery solution (1 mM EDTA, 5 mM Tris [pH 8.0]) for 15–20 min,
and cooled for 20–30 min at 4C. Sections were blocked in 10%
normal goat serum in PBSwith 0.1% Tween 20 (PBT) for 1 hr before
addingantibodies. Sectionswere incubatedwithprimaryantibodies
overnight at 4C and visualized using goat anti-rabbit and/or anti-
chick IgG-Alexa Fluor 488, goat anti-mouse and/or rabbit IgG-Alexa
Fluor 546 (1:300; Molecular Probes), and goat anti-rabbit IgG-Cy5
(1:300; Invitrogen) for 1.5 hr at room temperature. Images were
capturedusingaLeicadigital cameraunder afluorescentmicroscope
(Leica DMI6000B) or a Zeiss confocal microscope. Primary anti-
bodies against the following antigens were used: BRDU (1:50;
DSHB, catalog no. G3G4, mouse), KI67 (1:500; Abcam, catalog no.Stem Cell Reports j Vol. 7 j 69–79 j July 12, 2016 77
ab15580, rabbit), PAX6 (1:200; Covance, catalog no. PRB-278P,
rabbit), TBR1 (1:2500; Abcam, catalog no. ab31940, rabbit), TBR2
(1:500;Abcam, catalogno. ab23345, rabbit), SATB2 (1:1000;Abcam,
catalog no. ab51502, rabbit), CDK7 (1:300; Santa Cruz, catalog no.
sc-529, rabbit), NESTIN (1:10; DSHB, catalog no. Rat-401, mouse),
GFP (1:1000; Abcam, catalog no. ab13970, chicken), and CASP3
(1:1000; R&D Systems, catalog no. AF835, rabbit).
Quantitative Real-Time RT-PCR
Total RNAwas isolated fromthedorsal cortex of E13.5, E15.5, E17.5,
and P0 wild-type CD1 mice using the RNeasy Mini kit (QIAGEN)
according to the manufacturer’s instructions. All samples were
treated with DNase to remove genomic DNA. Reverse transcription
was performed using a RandomHexamer primer (Roche). qRT-PCR
was performed using Power SYBR Green PCR Master Mix (Life Sci-
ence) and Mx4000 Multiplex qPCR System (Stratagene) according
to the manufacturer’s instructions. RT primers for primary miR-
210 (pri-miR-210) and internal control glyceraldehyde 3-phos-
phate-dehydrogenase (Gapdh) are listed as follows:
pri-miR-210 F: 50-GGG GGC GGA GAG GAG GAC-30, R: 50-AGA
TCA GCC GCT GTC ACA C-30; Gapdh: F: 50-ACT CCA CTC ACG
GCA AAT TC-30, R: 50-CTA AGC AGT TGG TGG TGC AG-30.
Statistics
For immunostaining, at least four sections from each brain and
three brains were chosen for antibody labeling. For qRT-PCR,
each sample was tested in triplicate. Statistical comparisons were
made by an ANOVA (unpaired Student’s t test).
Full details on the methods used are presented in the Supple-
mental Experimental Procedures.
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